Quick Answer
RxSight, Inc. reported Total Revenue of $134.48 million for the year ending 2025.
- RxSight, Inc. showed a decrease of -3.9% in Total Revenue from 2024 to 2025.
- This data is from RxSight, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $2.71 million | Q3 2020: $4.17 million | Q1 2021: $3.48 million | Q2 2021: $4.90 million | Q3 2021: $5.79 million | Q1 2022: $8.94 million | Q2 2022: $11.36 million | Q3 2022: $12.62 million | Q1 2023: $17.49 million | Q2 2023: $20.81 million | Q3 2023: $22.20 million | Q1 2024: $29.51 million | Q2 2024: $34.89 million | Q3 2024: $35.31 million | Q1 2025: $37.90 million | Q2 2025: $33.64 million | Q3 2025: $30.34 million.
- Over the full 6 years of available data (2020 to 2025), RxSight, Inc.'s Total Revenue has grown by 816.2%.
- Historical annual values: Fiscal year 2025: $134.48 million | Fiscal year 2024: $139.93 million | Fiscal year 2023: $89.08 million | Fiscal year 2022: $49.01 million | Fiscal year 2021: $22.59 million | Fiscal year 2020: $14.68 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: